SUPIROCIN

This brand name is authorized in Hong Kong SAR China, Nigeria, Singapore.

Active ingredients

The drug SUPIROCIN contains one active pharmaceutical ingredient (API):

1	Mupirocin UNII D0GX863OA5 - MUPIROCIN
	Mupirocin is a novel antibiotic produced through fermentation by Pseudomonas fluorescens. Mupirocin inhibits isoleucyl transfer-RNA synthetase, thereby arresting bacterial protein synthesis. Mupirocin has bacteriostatic properties at minimum inhibitory concentrations and bactericidal properties at the higher concentrations reached when applied locally.
	Read more about Mupirocin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D06AX09	Mupirocin	D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06A Antibiotics for topical use → D06AX Other antibiotics for topical use
Discover more medicines within D06AX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	51535
NG	Registered Drug Product Database	04-7547
Switch country to Nigeria in order to find specific presentations of SUPIROCIN
SG	Health Sciences Authority	11895P